Inbiose
Chemicals & Related Products · Belgium · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gent, Flanders, 9052, BelgiumPhone Number
+32 92415710Website
www.inbiose.comRevenue
$5.5 MillionIndustry
About Inbiose
Is Inbiose your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Inbiose
Earning: See what the market has to say on Inbiose recently announced quarterly report
Inbiose, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Inbiose has recently received funding, and reach out quickly before it becomes old news!
Click to see if Inbiose had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Inbiose launches new products
Check out if Inbiose is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Inbiose has new funding data
Recommended Actions
Find VP level buyers at Inbiose
Find 2 more new buyers
Company Profile Activity
Activity Insights
Inbiose is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inbiose is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inbiose.
Inbiose Tech Stack
A closer look at the technologies used by Inbiose
Inbiose News & Media
Human Milk Oligosaccharides (HMOs) Market Latest Trending Report Is Booming Globally by Top Leading Players Inbiose NV, Glycom A/S, Elicityl, Medolac, Etc
New York, NY -- (SBWIRE) -- 11/09/2020 -- The Human Milk Oligosaccharides (HMOs) market size was valued at USD 78.82 Million in 2018. It is expected to grow at a CAGR of 15.3% to reach USD 238.80 Million in value by 2026 Read the full press release at http://www.sbwire.com/press-releases/human-milk-oligosaccharides-hmos-market-latest-trending-report-is-booming-globally-by-top-leading-players-inbiose-nv-glycom-as-elicityl-medolac-etc-1315350.htmInbiose is Fast Tracking 7 HMOs from its Portfolio for use in Infant Formula and Health Markets
Inbiose announces that it has extended its offering to 7 human milk oligosaccharides for which efficient processes become available for large-scale manufacturing and commercialization. Long awaited by the baby food industry, the commercial availability of these HMOs will bring great new opportunities to further improve Infant Milk Formula and to get closer to the all-time gold standard, human breast milk. (PRWeb October 18, 2018) Read the full story at https://www.prweb.com/releases/inbiose_is_f
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inbiose
Inbiose is a global leader in the development and production of Human Milk Oligosaccharides (HMOs), which are clinically validated ingredients designed to enhance health across various life stages, including infants, adults, and pets. Their offerings include solutions for early life nutrition, dietary supplements, food and beverages, and pet nutrit... Read More